ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 406 out of 972

$649K Total Retail Price of All Prescriptions

Rank: 177 out of 972

373 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,993 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 384 379 1 3
AMLODIPINE BESYLATE 249 239 2 4
SIMVASTATIN 230 221 3 2
LOSARTAN POTASSIUM 177 166 4 17
OMEPRAZOLE 175 171 5 5
ATORVASTATIN CALCIUM 166 154 6 11
POTASSIUM CHLORIDE 165 144 7 13
FUROSEMIDE 162 150 8 7
LISINOPRIL 159 136 9 1
NEXIUM 134 107 10 30
HYDROCHLOROTHIAZIDE 132 101 11 10
CRESTOR 127 119 12 33
METOPROLOL SUCCINATE 112 106 13 16
WARFARIN SODIUM 97 80 14 12
TRAMADOL HCL 95 79 15 15
METFORMIN HCL ER 93 87 16 62
ALLOPURINOL 90 86 17 28
GABAPENTIN 77 66 18 14
BYSTOLIC 76 74 19 102
TAMSULOSIN HCL 75 66 20 29
ADVAIR DISKUS 74 60 21 45
SPIRIVA 73 67 22 56
METOPROLOL TARTRATE 72 57 23 9
NATEGLINIDE 67 67 24 440
ISOSORBIDE MONONITRATE ER 64 64 25 43
JANUVIA 60 50 26 75
TRIAMTERENE-HCTZ 60 58 26 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 60 58 26 166
HYDROCODONE-ACETAMINOPHEN 57 40 S3 29 6
NIFEDIPINE ER 56 45 30 116
FLUTICASONE PROPIONATE 56 56 30 31
AMITRIPTYLINE HCL 54 46 R 32 58
CARVEDILOL 54 49 32 21
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 34 61
AZELASTINE HCL 53 50 34 296
LANTUS SOLOSTAR 52 44 36 86
FAMOTIDINE 51 47 37 73
METFORMIN HCL 51 49 37 8
ATENOLOL 50 36 39 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.